Relmada Therapeutics, Inc. SEC filings RLMD
Relmada Therapeutics, Inc. has 606 filings in SEC EDGAR's recent list, going back to Nov 13, 2012. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Sep 11, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Other events
|
Sep 8, 2026 | Sep 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 28, 2026 | Jul 28, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 22, 2026 | — |
| S-8 | Employee stock plan registration | Jun 18, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 9, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 28, 2026 | May 27, 2026 |
| S-3ASR | Automatic shelf registration | May 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 4, 2026 | — |
| DEFA14A | Additional proxy material | Apr 17, 2026 | — |
| DEF 14A | Proxy statement | Apr 17, 2026 | May 27, 2026 |
| EFFECT | Filing | Apr 9, 2026 | — |
| 424B3 | Prospectus | Apr 9, 2026 | — |
| CORRESP | Letter to the SEC | Apr 7, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 6, 2026 | Apr 6, 2026 |
| S-3 | Shelf registration | Apr 3, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 20, 2026 | Mar 19, 2026 |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Mar 9, 2026 | Mar 9, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 6, 2026 | — |
| 424B5 | Prospectus supplement | Jan 30, 2026 | — |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2025 | Dec 12, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Nov 6, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 6, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 6, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 6, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 5, 2025 | Nov 4, 2025 |
| 424B5 | Prospectus supplement | Nov 5, 2025 | — |
| FWP | Free writing prospectus | Nov 4, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 17, 2025 | Sep 17, 2025 |
| 8-K |
Current report
Other events
|
Sep 16, 2025 | Sep 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 10, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 2, 2025 | Aug 29, 2025 |
| 4 | Insider transaction | Aug 28, 2025 | Aug 26, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2025 | Aug 7, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Listing notice
|
Jul 23, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Agreement ended
|
Jul 10, 2025 | Jul 7, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2025 | Jun 17, 2025 |
| S-8 | Employee stock plan registration | Jun 13, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
May 27, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Auditor change
|
May 12, 2025 | May 8, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 1, 2025 | — |
| 424B5 | Prospectus supplement | Apr 28, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 28, 2025 | Apr 28, 2025 |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| DEF 14A | Proxy statement | Apr 11, 2025 | May 23, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Mar 26, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Feb 6, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 27, 2025 | Jan 21, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 6, 2025 | Jan 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 9, 2024 | Dec 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 4, 2024 | Dec 4, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 23, 2024 | Oct 22, 2024 |
| EFFECT | Filing | Sep 12, 2024 | — |
| 4 | Insider transaction | Sep 11, 2024 | Sep 9, 2024 |
| 4 | Insider transaction | Sep 11, 2024 | Sep 9, 2024 |
| 4 | Insider transaction | Sep 11, 2024 | Sep 9, 2024 |
| 4 | Insider transaction | Sep 11, 2024 | Sep 9, 2024 |
| CORRESP | Letter to the SEC | Sep 11, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2024 | — |
| S-3 | Shelf registration | Aug 30, 2024 | — |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 30, 2024 | May 24, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 24, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 24, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 24, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 24, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 24, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 24, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 24, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| DEFA14A | Additional proxy material | Apr 9, 2024 | — |
| DEF 14A | Proxy statement | Apr 9, 2024 | May 24, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2024 | Mar 19, 2024 |
| 10-K | Annual report | Mar 19, 2024 | Dec 31, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 6, 2024 | — |
| 144 | Notice of proposed sale | Feb 20, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 4 | Insider transaction | Jan 31, 2024 | Jan 29, 2024 |
| 4 | Insider transaction | Jan 31, 2024 | Jan 29, 2024 |
| 4 | Insider transaction | Jan 31, 2024 | Jan 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 11, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 3, 2024 | Jan 3, 2024 |
| 4 | Insider transaction | Dec 19, 2023 | Dec 15, 2023 |
| 4 | Insider transaction | Dec 19, 2023 | Dec 15, 2023 |
| 4 | Insider transaction | Dec 19, 2023 | Dec 15, 2023 |
| 4 | Insider transaction | Dec 19, 2023 | Dec 15, 2023 |
| 4 | Insider transaction | Dec 19, 2023 | Dec 15, 2023 |
| 4 | Insider transaction | Dec 19, 2023 | Dec 15, 2023 |
| 4 | Insider transaction | Dec 19, 2023 | Dec 15, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 11, 2023 | Oct 11, 2023 |
| 8-K |
Current report
Other events
|
Oct 10, 2023 | Oct 10, 2023 |
| 8-K |
Current report
Other events
|
Oct 4, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 20, 2023 | Sep 20, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 6, 2023 | Sep 5, 2023 |
| 8-K |
Current report
Other events
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 7, 2023 | — |
| S-8 | Employee stock plan registration | Jun 21, 2023 | — |
| 4 | Insider transaction | May 30, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 30, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 30, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 30, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 30, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 30, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 30, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 30, 2023 | May 25, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 25, 2023 | May 25, 2023 |
| 4 | Insider transaction | May 24, 2023 | May 23, 2023 |
| 8-K |
Current report
Other events
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Other events
|
Apr 19, 2023 | Apr 19, 2023 |
| DEFA14A | Additional proxy material | Mar 31, 2023 | — |
| DEF 14A | Proxy statement | Mar 31, 2023 | May 25, 2023 |
| 10-K | Annual report | Mar 23, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 10, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2023 | — |
| 5/A | Ownership document | Feb 6, 2023 | Dec 31, 2022 |
| 5 | Annual insider ownership | Feb 2, 2023 | Dec 31, 2022 |
| 5 | Annual insider ownership | Feb 2, 2023 | Dec 31, 2022 |
| 5 | Annual insider ownership | Feb 2, 2023 | Dec 31, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 1, 2023 | — |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jan 17, 2023 | Jan 12, 2023 |
| 3 | Initial insider ownership | Jan 13, 2023 | Jan 12, 2023 |
| 4 | Insider transaction | Jan 13, 2023 | Jan 6, 2023 |
| 3 | Initial insider ownership | Jan 13, 2023 | Jan 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 5, 2023 | Jan 1, 2023 |
| 8-K |
Current report
Material agreement
|
Dec 28, 2022 | Dec 27, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 20, 2022 | Dec 16, 2022 |
| SC 13G | Ownership over 5% (passive) | Dec 20, 2022 | — |
| 4 | Insider transaction | Dec 12, 2022 | Dec 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 7, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Other events
|
Nov 14, 2022 | Nov 11, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2022 | Nov 10, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RLMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Coral Gables, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1553643
- Former names
- CAMP NINE, INC. (until Jul 14, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.